Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Final Prespecified OS Analysis of CLEAR - 4-Year Follow-Up of Lenvatinib + Pembro vs. Sunitinib in Patients With Advanced RCC"

291 views
June 27, 2023
0 Comments
Login to view comments. Click here to Login
GU